Concerns Over RSV Vaccine Approval and Alternative Prevention Strategies

This chapter examines the risks associated with a newly approved RSV shot, emphasizing the questionable timing of its trials and the potential for increased vulnerability to infection. It calls for ongoing transparency and monitoring post-release, while suggesting alternative strategies to enhance natural immunity in infants.